M MT1 (Metoprolol succinate extended-release 25 mg)
Pill imprint M MT1 has been identified as Metoprolol succinate extended-release 25 mg.
Metoprolol is used in the treatment of atrial fibrillation; high blood pressure; supraventricular tachycardia; heart attack; angina (and more), and belongs to the drug class cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Metoprolol 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- M MT1
- Strength:
- 25 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Cardioselective beta blockers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-4595
- Inactive Ingredients:
- silicon dioxide
ethylcelluloses
hypromelloses
lactose monohydrate
microcrystalline cellulose
polyethylene glycol
sodium stearyl fumarate
titanium dioxide
triacetin
More about metoprolol
Consumer resources
- Metoprolol
- Metoprolol succinate extended-release tablets
- Metoprolol (Advanced Reading)
- Metoprolol Intravenous (Advanced Reading)
- Other brands: Metoprolol Tartrate, Metoprolol Succinate ER, Toprol-XL, Lopressor
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
